z-logo
open-access-imgOpen Access
pncA mutations in mycobacterium tuberculosis is a strong predictor of poor treatment outcome in the therapy of multidrug resistant tuberculosis
Author(s) -
Dongye Li,
Yi Hu
Publication year - 2016
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2016.02.246
Subject(s) - medicine , pyrazinamide , tuberculosis , mycobacterium tuberculosis , cohort , sputum , drug resistance , multi drug resistant tuberculosis , multiple drug resistance , genotype , oncology , gene , genetics , pathology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom